CLINICAL_TRIALS
trial_result
· 2023-08-23
Clinical Trial Update: HEALEY ALS Platform Trial - Regimen D Pridopidine [Phase 2, Phase 3]
Summary
Phase 2/3 results for pridopidine in Regimen D within the HEALEY ALS Platform Trial for amyotrophic lateral sclerosis have been completed and results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merit E. Cudkowicz, MD | Conditions: Amyotrophic Lateral Sclerosis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2023-08-23